Goldman Sachs reiterates Neutral on Tesla stock, $375 target By Investing.com

Tesla beat Q1 expectations with EPS of $0.41 versus $0.36 consensus and revenue of $22.39B versus $22.28B expected, supported by higher Auto and Energy margins. However, the company raised capex guidance to more than $25B and now expects negative free cash flow for the rest of 2026, tempering the earnings beat. Goldman Sachs kept a Neutral rating and $375 price target, while TD Cowen reiterated Buy with a $490 target on autonomous vehicle and robotics catalysts.

Analysis

The market is reacting to a classic quality-of-earnings problem: the quarter looked better, but the path to durable upside got more capital-intensive and more back-end loaded. When a company with a stretched multiple is forced to raise capex while simultaneously guiding to negative free cash flow, the valuation regime usually shifts from “execution premium” to “proof premium” — investors will demand evidence that incremental dollars are producing scalable autonomy or energy returns, not just preserving the growth narrative.

The second-order implication is that Tesla’s real competitive battleground is moving from unit economics to capital allocation. A higher capex envelope likely benefits battery, compute, manufacturing automation, and infrastructure suppliers, while pressuring any adjacent EV OEM that lacks Tesla’s balance sheet flexibility. But it also raises the bar for peers and for Tesla itself: if autonomy commercialization slips even 6-12 months, the market will start discounting the spend as defensive rather than strategic, which can compress the multiple faster than fundamentals deteriorate.

The underappreciated risk is that improved margins driven partly by accounting items can create a near-term sell-the-news setup when sell-side models roll forward. With the stock already pricing in a long-dated autonomy option, the next leg higher likely requires a catalyst that is visible within 1-2 quarters — not a vague 2026 roadmap. That makes the stock more sensitive to delivery mix, FSD attach rates, and any hint that robotaxi deployment remains small-scale rather than replicable.

Consensus may be missing that the capex hike is not just a growth signal; it is a financing signal. If free cash flow stays negative into 2026, the market will begin to treat Tesla less like a software compounder and more like a capital-intensive industrial with optionality, which can force multiple compression even if earnings estimates hold. The tradeable edge is to separate the operating story from the valuation story: bullish on long-dated autonomy, cautious on the near-term equity risk/reward.

Key Decisions for Investors

• Fade the post-earnings bounce in TSLA via a 1-3 month put spread or call overwrite: upside is capped by capex/FCF concerns, while downside can re-rate quickly if the market focuses on capital intensity rather than margin beat.
• If long TSLA for autonomy optionality, use a staggered entry after the next delivery/FSD data point rather than now; the risk/reward improves only if near-term metrics confirm that subscription growth is translating into monetizable usage.
• Pair trade: long high-quality EV/battery supply chain beneficiaries with visible capex leverage, short TSLA against them only if autonomy milestones slip — this isolates the capital-expenditure theme from the multiple-risk theme.
• Watch for a 6-12 month catalyst window: if robotaxi deployment remains small or Unsupervised FSD commentary gets pushed out again, reduce any TSLA long exposure by 25-50% because the market will likely start discounting 2026 guidance much more aggressively.
• For event-driven accounts, consider selling downside protection into implied-volatility spikes around delivery/AI-autonomy updates only if you can tolerate gap risk; the stock remains headline-sensitive and can overshoot on any credible autonomy announcement.